Osteomyelitis is associated with increased anti-inflammatory response and immune exhaustion.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 06 03 2024
accepted: 12 04 2024
medline: 13 5 2024
pubmed: 13 5 2024
entrez: 13 5 2024
Statut: epublish

Résumé

Osteomyelitis (OMS) is a bone infection causing bone pain and severe complications. A balanced immune response is critical to eradicate infection without harming the host, yet pathogens manipulate immunity to establish a chronic infection. Understanding OMS-driven inflammation is essential for disease management, but comprehensive data on immune profiles and immune cell activation during OMS are lacking. Using high-dimensional flow cytometry, we investigated the detailed innate and adaptive systemic immune cell populations in OMS and age- and sex-matched controls. Our study revealed that OMS is associated with increased levels of immune regulatory cells, namely T regulatory cells, B regulatory cells, and T follicular regulatory cells. In addition, the expression of immune activation markers HLA-DR and CD86 was decreased in OMS, while the expression of immune exhaustion markers TIM-3, PD-1, PD-L1, and VISTA was increased. Members of the T follicular helper (Tfh) cell family as well as classical and typical memory B cells were significantly increased in OMS individuals. We also found a strong correlation between memory B cells and Tfh cells. We conclude that OMS skews the host immune system towards the immunomodulatory arm and that the Tfh memory B cell axis is evident in OMS. Therefore, immune-directed therapies may be a promising alternative for eradication and recurrence of infection in OMS, particularly in individuals and areas where antibiotic resistance is a major concern.

Identifiants

pubmed: 38736874
doi: 10.3389/fimmu.2024.1396592
pmc: PMC11082283
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1396592

Informations de copyright

Copyright © 2024 Surendar, Hackenberg, Schmitt-Sánchez, Ossendorff, Welle, Stoffel-Wagner, Sage, Burger, Wirtz, Strauss and Schildberg.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Jayagopi Surendar (J)

Department of Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany.

Roslind K Hackenberg (RK)

Department of Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany.
Department of Hand, Plastic and Reconstructive Surgery, Burn Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Ludwigshafen, Germany.

Fabio Schmitt-Sánchez (F)

Department of Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany.

Robert Ossendorff (R)

Department of Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany.

Kristian Welle (K)

Department of Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany.

Birgit Stoffel-Wagner (B)

Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.

Peter T Sage (PT)

Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.

Christof Burger (C)

Department of Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany.

Dieter C Wirtz (DC)

Department of Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany.

Andreas C Strauss (AC)

Department of Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany.

Frank A Schildberg (FA)

Department of Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH